SCOTTSDALE, Ariz., Dec. 06, 2023 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical” or “the Company”), a commercial-stage pharmaceutical company that primarily focuses ...
Journey Medical Corporation's DERM shares rose 10% on Mar 18, after the company announced that its new drug application (NDA) for its key pipeline candidate, DFD-29 capsules (40mg), to treat ...
Sedana Medical AB (publ) announces that the company has completed its pre-NDA meeting with FDA and reached broad alignment with the Agency on the contents of the New Drug Application (NDA). FDA confir ...
Shanghai Junshi Biosciences Co., Ltd (Junshi Biosciences, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization ...
ROCKVILLE, Md. and SUZHOU, China, Nov. 23, 2023 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and ...
TYNGSBORO — Even after graduation, the young women of the Academy of Notre Dame remain a strong part of the school’s family. Just like any family, their successes and achievements are celebrated.
Egalet Corporation (Nasdaq: EGLT) ("Egalet"), a fully integrated specialty pharmaceutical company focused on developing, manufacturing and commercializing innovative treatments for pain and other ...
ROCHELLE, Va., Aug. 29, 2019 /PRNewswire-PRWeb/ -- NDA Partners Chief Executive Officer Earle Martin announced today that the company has been named as one of the Top Ten Medical Device Consulting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback